|
|
||||||||


*
Third Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan; and
Department of Molecular Biology, Nagoya City University School of Medicine, Nagoya, Japan
Rats pretreated with traces of LPS developed acute fatal shock syndrome after i.v. administration of a mAb that inhibits the function of a membrane complement regulatory molecule. Such a shock was not observed after the administration of large amounts of LPS instead of the mAb following LPS pretreatment. The lethal response did not occur in rats depleted of either leukocytes or complement, and a C5a receptor antagonist was found to inhibit the reaction. Furthermore, LPS-treated rats did not suffer fatal shock following the injection of cobra venom factor, which activates complement in the fluid phase so extensively as to exhaust complement capacity. Therefore, complement activation on cell membranes is a requirement for this type of acute reaction.
This article has been cited by other articles:
![]() |
S. Asai, T. Sato, T. Tada, T. Miyamoto, N. Kimbara, N. Motoyama, H. Okada, and N. Okada Absence of Procarboxypeptidase R Induces Complement-Mediated Lethal Inflammation in Lipopolysaccharide-Primed Mice J. Immunol., October 1, 2004; 173(7): 4669 - 4674. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fujita, I. Farkas, W. Campbell, L. Baranyi, H. Okada, and N. Okada Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a J. Immunol., May 15, 2004; 172(10): 6382 - 6387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Strachan, T. M. Woodruff, G. Haaima, D. P. Fairlie, and S. M. Taylor A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats J. Immunol., June 15, 2000; 164(12): 6560 - 6565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |